Innate Pharma SA Adjustments For Decrease Increase In Accrued Income Including Contract Assets
Innate Pharma SA (IPHYF) reported Adjustments For Decrease Increase In Accrued Income Including Contract Assets of -EUR 352.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets · last filed 2026-04-01
| Period end | Adjustments For Decrease Increase In Accrued Income Including Contract Assets 6 month | Adjustments For Decrease Increase In Accrued Income Including Contract Assets 12 month |
|---|---|---|
| 2025-12-31 | -352.00K EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | -191.00K EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | -380.00K EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | -212.00K EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 0.00 EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | -130.00K EUR 6-K · filed 2024-09-12 |